News - Page 154 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psilera Collaborates with the National Institute on Drug Abuse (NIDA) to Research DMT and New Analogues to Combat Addiction

Psilera Collaborates with the National Institute on Drug Abuse (NIDA) to Research DMT and New Analogues to Combat Addiction

Post published:August 26, 2021
Post category:Press Release

Read more about the article Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next Generation Psychedelic Compounds

Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next Generation Psychedelic Compounds

Post published:August 26, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering

MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering

Post published:August 26, 2021
Post category:Press Release

Read more about the article MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics in North America

MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics in North America

Post published:August 26, 2021
Post category:Press Release

Read more about the article Silo Pharma Advances Psychedelic Patent Portfolio

Silo Pharma Advances Psychedelic Patent Portfolio

Post published:August 25, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

Post published:August 25, 2021
Post category:Press Release

Read more about the article Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Post published:August 25, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

Post published:August 24, 2021
Post category:Press Release

Read more about the article Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates

Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates

Post published:August 24, 2021
Post category:Press Release

Read more about the article CB Therapeutics Expands Biomanufacturing IP Portfolio

CB Therapeutics Expands Biomanufacturing IP Portfolio

Post published:August 24, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.